The Interventional Cardiology and Cardiothoracic Research department is based at Castle Hill Hospital. Our research projects include commercial, non-commercial and in-house clinical trials which cover a wide variety of heart conditions such as Coronary Heart Disease (including angina and heart attack); and arrhythmias such as Atrial Fibrillation (AF). We conduct a number of clinical trials involving a range of treatments for these conditions such as PCI (PPCI), coronary artery bypass graft, valve surgery, ablation, and treatment with various medications. We aim to focus on studies that will benefit our patient groups and improve the care and/or treatment we are currently providing.

Our current research interests include

  • Drug studies looking at new anti-coagulation treatments for atrial fibrillation ablation.
  • New treatments for managing high cholesterol in patients with heart disease and acute coronary syndrome, including genetics.
  • New practices to manage patients who have had a heart attack requiring PPCI/PCI.
  • Studies comparing strategies for managing patients with exertional angina.
  • A number of observational studies looking at atrial fibrillation management.
  • Improving patient outcomes in patients with CAD or Arrhythmias.
  • Post cardiac surgery rehabilitation programmes.
  • Post thoracic surgery pain assessment.
  • Valve replacement surgical approach.
  • Post valve replacement anti coagulation therapies.

For further information on our research or how to get involved please contact:

Interventional Cardiology and Cardiothoracic Surgery Research

Ward 6/7 Corridor

Castle Hill Hospital

Call us on 01482 626767

Email us at